Faces Of Digital Health
EHDS and Pharma: Impact on R&D and Unresolved Challenges
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:17:45
- Mais informações
Informações:
Sinopse
1 view Mar 19, 2026 In-person video interviewsThe European Health Data Space (EHDS) isn't just a new regulation—it’s a "Magna Carta" for healthcare innovation. In this interview from the Smart Bridges Event, we sit down with industry expert Dennis Geisthardt, Head of digital.lab, to break down the implementation timeline (2025–2031) and what it means for the pharmaceutical industry, medtech, and patients across Europe. We dive into the "Countdown to 2027," the challenges of intellectual property vs. data sharing, and how opening up access to clinical data could finally unlock breakthroughs for rare diseases and personalized medicine. In this video, you’ll learn: The 3 major milestones of EHDS implementation (2027, 2029, 2031). Why "Primary Use" vs. "Secondary Use" of data matters for your healthcare. The risks and rewards for the private sector and Big Pharma. How EHDS could revolutionize market access (AMNOG) and AI-driven drug discovery. 00:30 – Introduction: The Smart Bridges Even